S

Smith+Nephew

Global medical devices for orthopedics

Global Category Manager - Implants

Full-TimeUpdated on 10/14/2026
No salary listed
Mid
Beijing, China
In Person
Operations & LogisticsProcurement & Sourcing

About the job

Requirements
  • At least 3 years of experience in strategic sourcing, supplier management, procurement, or supply-chain operations within a manufacturing or regulated industry.
  • Strong analytical and problem-solving capabilities, including cost analysis, financial acumen, project management skills, and understanding of contract structures and terms.
  • Ability to influence stakeholders at all organizational levels and build strong supplier partnerships, with interpersonal, communication, and presentation skills.
  • Knowledge of direct material categories, including forging, casting, machining, finishing, polishing, and associated secondary operations.
  • Understanding of commodity inputs such as titanium, stainless steel, cobalt chrome, and zirconium, and how these materials affect cost, supply, and product strategy.
  • Experience in supplier selection, qualification, negotiation, and performance management, including onboarding new suppliers and managing complex or global supply categories.
  • Working knowledge of manufacturing processes and ability to evaluate supplier capabilities to ensure supply continuity, cost deflation, and operational performance.
  • Proficiency with ERP/SAP and MRP systems, procurement tools, Microsoft Office applications (Excel, PowerPoint, and Word), and data and market analysis tools.
Responsibilities
  • Oversee day-to-day supplier management activities to ensure consistent execution of sourcing strategies, compliance, and performance expectations.
  • Lead sourcing decisions within assigned categories, support the new product development process, implement supplier and part strategies, and monitor supplier performance.
  • Collaborate with peer Category Managers, product development teams, and cross-functional partners across Global Operations to align sourcing decisions with business needs.
  • Provide supplier guidance on best practices, compliance requirements, pricing expectations, and delivery standards.
  • Analyze total spending, pricing structures, commercial terms, and market trends across raw materials, components, semi-finished goods, and finished goods to inform sourcing strategies.
  • Use market knowledge, including cost drivers and supply-and-demand dynamics, to strengthen sourcing decisions and competitive positioning.
  • Set strategic direction for global component sourcing, including castings and forgings for medical devices, and align with the Category Manager on global raw material strategies as needed.
  • Partner with Global Procurement and Operations to develop and execute global commodity strategies where applicable.
  • Work with business leaders, suppliers, and customers to create sourcing arrangements that reduce cost and risk, and negotiate complex contracts for strategic materials.
  • Develop understanding of product lines, market strategy, competitive landscape, and technologies to link raw material costs to product pricing.
  • Lead cross-functional initiatives to identify, qualify, negotiate, and onboard suppliers; apply manufacturing process knowledge to ensure supply continuity, cost deflation, and profitability.
  • Build cross-functional relationships with stakeholders in Manufacturing Operations, Quality Compliance, Engineering, Supplier Quality, Finance, and Regulatory.
  • Apply Six Sigma and Lean methodologies to improve sourcing processes, supplier productivity, and supplier development.
  • Manage complex projects and supplier relationships while implementing programs that drive QCDD performance and reduce operational and supply-chain risk.
  • Respond to internal and external SCN activity, NCRs, and audit findings related to supplier management in partnership with the Supplier Quality Team.
  • Analyze cost structures and cost-planning data to develop and execute cost-reduction strategies that meet financial targets while mitigating supplier risk; develop standard budgets and deliver PPV savings performance.
  • Develop deep understanding of assigned commodities, including parts, processes, and supplier capabilities, and support supplier and part strategy execution for integration into new product launches.
  • Research and monitor industry trends in sourcing, technology, and market pricing.
  • Follow up consistently to ensure manufacturing requirements and business objectives are met or exceeded.
  • Negotiate high-value, complex components or critical materials using strategic, value-driven methodologies that support long-term business goals.
  • Identify and communicate risks or delays in onboarding critical suppliers, focusing on non-conformance with required standards.
  • Influence internal stakeholders by implementing procurement strategies that deliver the lowest total cost while maintaining competitive service levels.
Desired Qualifications
  • Medical device experience is a strong advantage.

About the company

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
  • New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
  • August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.

What critics are saying

  • Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
  • Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
  • A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.

What makes Smith+Nephew unique

  • Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
  • Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
  • ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Parental Leave

Fertility Treatment Support

Family Planning Benefits

Tuition Reimbursement

Wellness Program

Mental Health Support

Volunteer Time Off

Home Office Stipend

Phone/Internet Stipend

Discounted Stock Options

Health Savings Account/Flexible Spending Account

Employee Assistance Program

PTO/vacation?

Paid Sick Leave

Company News

Yahoo Finance
Oct 6th, 2026
Smith+Nephew launches CARTIHEAL AGILI-C cartilage repair implant in Europe

Smith+Nephew has launched its CARTIHEAL AGILI-C Cartilage Repair Implant in Europe. The product, already introduced in the US during 2024, will be featured at the International Cartilage Regeneration & Joint Preservation Society Summit in Porto, Portugal from 8-10 October. The implant, composed of aragonite (a naturally occurring calcium carbonate), acts as a biphasic scaffold to repair cartilage, restore bone and relieve pain. A recent study published in the American Journal of Sports Medicine showed the implant resulted in higher overall Knee injury and Osteoarthritis Outcome Scores versus surgical standard of care for all time points out to 60 months. The implant will initially launch in twelve countries including Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland and the UK.

Kalkine Media
Sep 10th, 2026
Smith+Nephew issues $700M 5.750% bonds due 2036 to refinance 2030 senior notes

Smith & Nephew has issued $700 million in senior notes with a 5.750% coupon maturing in 2036, netting $690.9 million after underwriting fees. The FTSE 100 medical technology firm will primarily use proceeds to fund a tender offer for its existing 2.032% senior notes due 2030, with remaining funds allocated to general corporate purposes. The refinancing replaces lower-yield debt with higher-coupon notes, reflecting current credit market conditions. BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and SMBC Nikko Securities America managed the transaction, which closed on 11 September 2026. Founded in Hull in 1856, Smith & Nephew operates across orthopaedics, sports medicine, ENT, and advanced wound management. The company employs approximately 17,000 people across 100 countries and reported annual sales of $6.2 billion in 2025.

Ticker Report
Sep 3rd, 2026
Corient Private Wealth LP Makes New $2 Million Investment in Smith & Nephew SNATS, Inc. $SNN

Corient Private Wealth LP purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 31,871 shares of the medical equipment provider’s stock, valued at approximately $1,999,000. Other large investors […]

Yahoo Finance
Aug 17th, 2026
Smith+Nephew launches FLOW FLEXTEND COBLATION Wand with adjustable-angle tip for complex hip procedures

Smith+Nephew has launched the FLOW FLEXTEND COBLATION Wand, a new radiofrequency resection device designed for complex hip procedures. The device features an adjustable-angle tip that provides enhanced joint access and tissue targeting in difficult-to-reach hip, knee, and shoulder anatomies. The wand incorporates Smith+Nephew's FLOW~IQ technology, which automatically balances saline outflow with COBLATION energy. Its design includes a precision electrode with an adjustable tip that improves access to targeted tissues whilst facilitating insertion and removal. The angle adjustment mechanism allows surgeons to set the desired position without continuous manual control. Early surgeon feedback has been positive, with users highlighting improved versatility in the central compartment and precise tissue preservation capabilities compared to existing instruments.

Yahoo Finance
Jul 21st, 2026
Smith+Nephew launches ASC Solutions strategy to help ambulatory surgery centres optimise costs and outcomes

Smith+Nephew has launched ASC Solutions, an enterprise strategy designed to help ambulatory surgery centres optimise costs, improve quality and enhance performance. The initiative provides ASCs with access to clinical expertise, procedural technologies and data analytics to support growth and patient outcomes in value-based care settings. The company is expanding its ASC ONE delivery model into an integrated platform that simplifies centre development and accelerates facility readiness. ASC ONE coordinates services including facility design, construction, financing and clinical enablement through a single point of contact. Smith+Nephew has partnered with STERIS Unity Health Centers, Brasfield & Gorrie, Ghafari and Hopper Healthcare to provide expertise across the ASC lifecycle. The model enables physician-led organisations and health systems to streamline vendor management whilst reducing complexity and improving execution timelines.